Fujitsu develops explainable AI for genomic medicine, improving cancer treatment planning.
Fujitsu develops explainable AI to improve genomic medicine and cancer treatment planning. The technology draws on multiple data formats, including text, images, and numerical data, to create knowledge graphs that enhance the accuracy of medical data interpretation. Fujitsu's explainable AI has been proven effective in classifying lung cancer types and predicting breast cancer patient survival rates.
May 09, 2024
3 Articles